• Susan Thomas of Georgia Tech Research Corporation will receive $450,000 in breast cancer research funding.

  • Cellphone Principles Help Microfluidic Chip Digitize Information on Living Cells

  • Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy

  • OCI has developed a method to detect ovarian cancer that is highly accurate in patients with Stage 1 disease.

  • Eva Lee

  • Mostafa El Sayed

  • Melissa Kemp

  • Jeffrey Skolnick

  • Eberhard Voit

  • John McDonald, Director ICRC

 

Georgia Tech has been a leader in the development of collaborative approaches to both cancer diagnostics and therapeutics. The mission of the Integrated Cancer Research Center (ICRC) is to facilitate integration of the diversity of technological, computational, scientific and medical expertise at Georgia Tech and partner institutions in a coordinated effort to develop improved cancer diagnostics and therapeutics. 

News & Events

Integrated Cancer Research Center Seed Grant

The goal of the ICRC Seed Grant Program is to stimulate new research programs in integrated...

Georgia Tech receives $450,000 Komen research grant
Susan Thomas of Georgia Tech Research Corporation will receive $450,000 in breast cancer research...

The Ovarian Cancer Institute and Georgia Tech Develop a Procedure to Detect Early-Stage Ovarian Cancer
OCI has developed a method to detect ovarian cancer that is highly accurate in patients with Stage...

Cellphone Principles Help Microfluidic Chip Digitize Information on Living Cells
Researchers at the Georgia Institute of Technology are using unique identifying number principles...

Ovarian Cancer Breakthrough
McDonald's work in developing a test for early-stage ovarian cancer profiled on 90.1 WABE.